Belgium-based early-stage fund with a highly concentrated portfolio. One of the earliest investors in Adyen (EUR50B+ public company). Writes EUR500K-EUR5M.
Hummingbird Ventures backed 1 Y Combinator company.

The genetic testing platform detecting and measuring disease.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.